Almonertinib and alflutinib show novel inhibition on rare EGFR S768I mutant cells
Clinical and Translational Oncology · 2024
DOI: 10.1007/s12094-024-03494-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Oncology, 2024. Verfasst von Xiangkai Wei und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The First Affiliated Hospital of Henan University, Henan University, No. 357, Ximen Avenue, Kaifeng, 475000, Henan, Chi…. Hauptthemen laut MEDLINE: ErbB Receptors, Mutation, Protein Kinase Inhibitors, Apoptosis. Die Arbeit nennt 23 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, The First Affiliated Hospital of Henan University, Henan University, No. 357, Ximen Avenue, Kaifeng, 475000, Henan, China.
- Translational Medicine Center, Huaihe Hospital of Henan University, Henan University, No. 115, Ximen Avenue, Kaifeng, 475000, China.
- Institutes of Traditional Chinese Medicine, School of Pharmacy, Henan University, Kaifeng, 475000, Henan, China.
- Department of Anesthesiology, The First Affiliated Hospital of Henan University, Henan University, No. 357, Ximen Avenue, Kaifeng, 475000, Henan, China. Wangy1528@126.com.
- Translational Medicine Center, Huaihe Hospital of Henan University, Henan University, No. 115, Ximen Avenue, Kaifeng, 475000, China. anlei@henu.edu.cn.
- Institutes of Traditional Chinese Medicine, School of Pharmacy, Henan University, Kaifeng, 475000, Henan, China. anlei@henu.edu.cn.
Zitieren
APA
Wei, X., Zhang, G., Liu, Q., Niu, Z., Chu, C., Liu, C., Wang, K., Li, L., Wang, R., Cui, W., Xu, H., Liu, C., Wang, Y., & An, L. (2024). Almonertinib and alflutinib show novel inhibition on rare EGFR S768I mutant cells. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-024-03494-5
Vancouver
Wei X, Zhang G, Liu Q, Niu Z, Chu C, Liu C, et al. Almonertinib and alflutinib show novel inhibition on rare EGFR S768I mutant cells. Clinical and Translational Oncology. 2024. doi:10.1007/s12094-024-03494-5
BibTeX
@article{Wei2024,
author = {Wei, Xiangkai and Zhang, Guoliang and Liu, Qian and Niu, Zhiyuan and Chu, Chunhong and Liu, Chenxue and Wang, Ke and Li, Lanxin and Wang, Rui and Cui, Wenrui and Xu, Huixia and Liu, Chenyang and Wang, Ying and An, Lei},
title = {Almonertinib and alflutinib show novel inhibition on rare EGFR S768I mutant cells},
journal = {Clinical and Translational Oncology},
year = {2024},
doi = {10.1007/s12094-024-03494-5}
}
EUVIMED